Get started
Author

Heinz Leibl

Observed names: H LEIBL, H Leibl, H. Leibl, HEINZ LEIBL, Heinz Leibl (11863616), Leibl, Heinz
Institution: Takeda (Austria)
ORCID: 0000-0003-1670-4267
Observed ORCID: 0000-0003-1670-4267
OpenAlex ID: A5060535400
Expression of Thy-1 Antigen by Murine Epidermal Cells
1983 · Erwin Tschachler, Gerold Schuler, et al. · Journal of Investigative Dermatology · 237
Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency
2012 · Richard L. Wasserman, Isaac Melamed, et al. · Journal of Allergy and Clinical Immunology · 152
PDF
Human Epidermal Cells Synthesize HLA-DR Alloantigens In Vitro upon Stimulation with γ-Interferon
1985 · Beatrix Volc-Platzer, Heinz Leibl, et al. · Journal of Investigative Dermatology · 92
Efficacy, Safety and Tolerability of a New 10% Liquid Intravenous Immune Globulin [IGIV 10%] in Patients with Primary Immunodeficiency
2006 · Joseph A. Church, Heinz Leibl, et al. · Journal of Clinical Immunology · 80
Efficacy, Safety, and Pharmacokinetics of a 10% Liquid Immune Globulin Preparation (GAMMAGARD LIQUID, 10%) Administered Subcutaneously in Subjects with Primary Immunodeficiency Disease
2011 · Richard L. Wasserman, Isaac Melamed, et al. · Journal of Clinical Immunology · 76
A controlled trial of intravenous immunoglobulin in multifocal motor neuropathy
2013 · Angelika F. Hahn, Said R. Beydoun, et al. · Journal of the Peripheral Nervous System · 73
Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficiencies
2008 · R Gustafson, A Gardulf, et al. · Clinical & Experimental Immunology · 71
Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America
2016 · Daniel Suez, Mark Stein, et al. · Journal of Clinical Immunology · 63
PDF
Inhibition of DNA Synthesis of Melanoma Cells by Azelaic Acid
1985 · Heinz Leibl, Georg Stingl, et al. · Journal of Investigative Dermatology · 56
Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies
2016 · M Borte, G Kriván, et al. · Clinical & Experimental Immunology · 54
PDF
Prospective open‐label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo‐ or agammaglobulinemia
2006 · J. Björkander, J. Nikoskelainen, et al. · Vox Sanguinis · 53
Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency
2016 · Richard L. Wasserman, Isaac Melamed, et al. · Journal of Clinical Immunology · 52
PDF
Recombinant Human Hyaluronidase Facilitated Subcutaneous Immunoglobulin Treatment in Pediatric Patients with Primary Immunodeficiencies: Long-Term Efficacy, Safety and Tolerability
2016 · Richard L Wasserman, Isaac Melamed, et al. · Immunotherapy · 40
PDF
Comparable modulation of human monocyte functions by commercial factor VIII concentrates of varying purity
1988 · JW Mannhalter, R Ahmad, et al. · Blood · 22
PDF
Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents
2019 · Daniel Suez, Gergely Kriván, et al. · Immunotherapy · 17
PDF
Nuclear translocation of estrogen-receptor complex and stimulation of RNA synthesis by estrogens of different biological potencies in the female rat pituitary
1980 · J. Spona, H. Leibl, et al. · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · 17
Humoral and cellular immunity induced by antigens adjuvanted with colloidal iron hydroxide
1999 · Heinz Leibl, Regine Tomasits, et al. · Vaccine · 16
IgG Subclasses and Antibody Response to Pneumococcal Capsular Polysaccharides in Children with Severe Sinopulmonary Infections and Asthma
1991 · Ewa Bernatowska-Matuszkiewicz, Malgorzata Pac, et al. · Immunological Investigations · 15
Efficacy and Safety of the New Intravenous Immunoglobulin IGIV 10% in Adults with Chronic Idiopathic Thrombocytopenic Purpura
2006 · Gyula Varga, Zuzana Volková, et al. · Transfusion Medicine and Hemotherapy · 14
Affinity Binding of Distinct Functional Fibronectin Domains to Immobilized Metal Chelates
1995 · B. Gmeiner, H. Leibl, et al. · Archives of Biochemistry and Biophysics · 14
Expression of the Ly-5 Alloantigenic System of Epidermal Cells
1985 · Heinz Leibl, Judith Hutterer, et al. · Journal of Investigative Dermatology · 13
Method for the isolation of biologically active monomeric immunoglobulin A from a plasma fraction
1996 · Heinz Leibl, Regine Tomasits, et al. · Journal of Chromatography B Biomedical Sciences and Applications · 11
Modulation of human monocyte functions by factor VIII-anti-factor VIII complexes present in an affinity-purified factor VIII product [letter; comment]
1990 · JW Mannhalter, R Ahmad, et al. · Blood · 11
Estrogen interaction with the anterior pituitary of female rats differential cytosol binding, nuclear translocation and stimulation of RNA synthesis by 17β-estradiol and tamoxifen
1980 · J SPONA, C BIEGLMAYER, et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 11
Tolerability of Subcutaneous Immunoglobulin 20%, Ig20Gly, in Pediatric Patients with Primary Immunodeficiencies
2019 · Kenneth Paris, Elie Haddad, et al. · Immunotherapy · 10
PDF
Works count: 86
Citation count: 1,400
H-index: 16
I10-index: 28
Year
Topic
Type